FDA dispute panel on Lifecore Biomedical put on hold
This article was originally published in Clinica
Executive Summary
The US FDA's decision-making abilities will not be subject to public scrutiny next week after all (see Clinica No 947, p 1) . The agency announced late last week that it has postponed its medical devices dispute resolution panel meeting, on a Lifecore Biomedical product, which was originally slated for this June 4.